- Design
- Prospective cohort follow-up (HAPO Follow-Up Study)
- Population
- 4,693 women assessed 10–14 years after delivery
- Primary outcome
- Prediabetes or diabetes at follow-up
- Effect
- Adjusted risk ratios 2.14–2.88 across insulin-deficient, insulin-resistant and mixed subtypes vs no GDM
This analysis used the prospective HAPO Follow-Up Study, which assessed 4,693 women 10 to 14 years after delivery. Gestational diabetes was classified by physiology: insulin deficient, insulin resistant, mixed defect, or unclassified.
Compared with women without gestational diabetes, the insulin-deficient, insulin-resistant and mixed-defect subtypes were each associated with roughly two to three times the risk of prediabetes or diabetes (adjusted risk ratios 2.14 to 2.88). All three were also linked to metabolic syndrome and higher predicted cardiovascular risk. Only the insulin-resistant subtype was associated with dyslipidaemia.
Subtyping has been proposed as a way to personalise follow-up. This study suggests it should not be used to reassure anyone. Any woman with a history of gestational diabetes deserves ongoing glucose and cardiovascular risk checks, which matters in India, where gestational diabetes is common and postpartum follow-up is often lost.
- Record a history of gestational diabetes in every woman's problem list.
- Offer glucose testing after delivery and then at regular intervals, whatever the subtype.
- Check blood pressure and waist circumference at the same visits.
- Add a lipid profile, especially where insulin resistance was prominent in pregnancy.
- Discuss weight and activity early; the risk accumulates over a decade.
Why it matters
Subtyping gestational diabetes does not pick out women who can safely skip follow-up.
Don't overread it
The unclassified subtype was too small (0.7%) to show it carries no risk.
The statistics, in plain English
An adjusted risk ratio of 2.14 means about twice the risk after accounting for measured differences such as age and BMI. This is observational, so it shows association; unmeasured factors may still contribute.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free